CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) Becomes One of First Publicly Traded Companies to Receive USDA Organic Certification for CBD Tinctures

HempFusion Wellness (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has received USDA Organic Certification for its HempFusion CBD tinctures; the exclusive line of tinctures offers products with potency from 150mg (5mg per serving) to 1,500mg (50mg per serving) of CBD per bottle. HempFusion is one of the first publicly traded CBD companies to receive the certification; the distinction is significant because organic products generally represent some of the highest quality products available. The process to certify its tinctures as USDA Organic started in 2018, and involve providing detailed documentation for every step in the growth, production and manufacturing process of the product ingredients. In addition, HempFusion was required to demonstrate that it met rigorous organic standards regarding it CBD tinctures. The company recently expanded its tincture line to include two new products, designed for consumers who are looking for more CBD per serving. These new products offer 30 and 50mg of CBD per serving or 900 and 1500mg of CBD per bottle, respectively. “Our team has worked meticulously to earn USDA Organic Certification, which supports our commitment to providing consumers with premium and differentiated CBD products as well as new potential distribution points,” said HempFusion co-founder and CEO Jason Mitchell in the press release. “This prestigious certification joins our many other compliance markers, further establishing HempFusion as a leader in the premium CBD category.”

To view the full press release, visit https://cnw.fm/oY2Oh

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW — NJ Cannabis Legalization Still in Legal Limbo After New Year Begins

On November 3 last year, voters in New Jersey overwhelmingly approved a ballot question asking whether the state should allow adults aged 21 and over to sell, possess and use cannabis. The Legislature and Cannabis Regulatory Commission was tasked with creating a regulatory framework for recreational cannabis, with a constitutional amendment that would officially legalize cannabis kicking in on Jan. 1, 2021. However, with lawmakers still negotiating key sections of the legislation, the state still hasn’t passed legislation that would launch the recreational market.

Robert Williams, a retired constitutional law professor at Rutgers Law School, says that nearly two months after voters approved cannabis legalization, the commission hasn’t created any regulations or implemented any laws, a situation he calls “odd.” Although state lawmakers have already crafted and passed enabling legislation consisting of two bills to set the ball rolling, Gov. Phil Murphy hasn’t signed any legislation into law.

The governor, who had cannabis legalization as one of his campaign platforms, is holding off on signing the legislation until lawmakers add a provision to levy fines on underage marijuana users. According to a proposed change his office sent to legislators, anyone younger than 21 found with one ounce or less of cannabis would be fined $250 while the possession of one to six ounces of cannabis would carry a $500 fine. Along with decriminalizing cannabis, the goal was also to ensure that minors were protected, Murphy says.

Activists also argue the bills don’t do enough for the communities that were disproportionately affected by marijuana laws. Police in New Jersey are particularly tough on marijuana crimes, with Black people being three and a half times more likely to be arrested for possession than white people, despite relatively similar usage rates. Other issues holding back the legislation include the capping of the number of available licenses for the first two years and giving employers the right to test their employees for THC.

Levying fines on underage people who use cannabis goes against the legislation’s objective, which is to limit interactions with police, especially among Black youth. ACLU of New Jersey executive director Amol Sinha asks why minors should be burdened with criminal records if the state is passing laws to clear criminal records of people with cannabis-related offenses.

With the cannabis legislation hanging in limbo, Attorney General Gurbir Grewal has asked state prosecutors at all levels to dismiss or, at the very least, delay any marijuana charges that would otherwise be considered legal under the pending legislation.

Aside from the legal gymnastics going on in New Jersey, cannabis firms elsewhere are thriving. For example, Green Hygienics Holdings Inc. (OTCQB: GRYN) is poised to grow its revenue explosively given that it has a capacity to cultivate more than 800 acres of USDA Certified Organic hemp while the average hemp farm in the entire North America is only 15 acres big.

NOTE TO INVESTORS: The latest news and updates relating to Green Hygienics Holdings Inc. (OTCQB: GRYN) are available in the company’s newsroom at http://cnw.fm/GRYN

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – MAZAKALI Highlights 2021’s Positioning as a Pivotal Year for the Cannabis Sector

MAZAKALI, the online platform for cannabis investments, recently discussed potential of the current cannabis industry in a GreenPaper(R) titled, “Cannabis 2021: Five Things To Watch.” The article reads, “For many, the 2020 lockdown experience was punctuated by Tiger King and The Queen’s Gambit, and also best viewed in hindsight. 2021 has arrived and is poised to be a pivotal year for the cannabis complex. The tailwinds of political support, ‘essential’ status, legalization in 70% of U.S. states, local government desire for tax revenue and increased public health focus are expected to drive a five-year 27% industry CAGR – making this industry one of the fastest growing in the world. A classic emerging market, it is likely that cannabis proves to be the best performing asset class this decade and also unlikely that any sector remains untouched by this plant as we continue our march toward global acceptance.”

To view the full article, visit https://cnw.fm/UHuHT

About MAZAKALI

Headquartered in San Francisco, MAZAKALI offers its Digital Capital Investment Platform to the global cannabis complex. Registered Investment Advisors customize investment portfolios via MAZAKALI’s Outsourced Cannabis Investment Officer (“OCIO”) service, and licensed Investment Bankers help operators with capital and M&A services. MAZAKALI’s leadership team began putting cannabis capital to work in 2014 and brings over 150 years of financial, strategic, legal, compliance and international business experience to clients across the global hemp and non-hemp cannabis (“NHC”) industries.

The MAZAKALI GreenPaper(R) has gained authority through knowledge on deep trends in the industry that matter to investors and operators alike. Securities are offered via a licensed broker/dealer.

MAZAKALI was founded to counteract the negative consequences of business practices that deplete resources by making investments in sustainable hemp and non-hemp cannabis. By shepherding capital in a responsible and ethical manner, MAZAKALI and its clients envision a world where cannabis capital investment will play a significant role Beyond Impact.

For more information, visit www.MAZAKALI.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Completion of Patient Enrollment for Study of Cannabidiol Lotion for Eczema Treatment

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”)-based medical therapeutics and wellness products, has completed patient enrollment in its upcoming clinical study of JW-100, its proprietary cannabidiol lotion formulation for the treatment of atopic dermatitis, or eczema. The study is designed to investigate the efficacy and safety of JW-100. JUPW enrolled 66 patients for the multi-center, double-blinded, placebo-controlled trial. Study participants will be randomly selected to receive one of three topical formulations, including a placebo, at least twice daily. Data from the study is expected in Q1 2021. “We are eager to see the results of this trial, and should JW-100 prove effective, we plan to use the data from this study to file an Investigational New Drug (‘IND’) application with the U.S. Food and Drug Administration,” said Jupiter CEO Brian John in the press release. “With the eczema market valued at more than $10 billion in 2020 and a high percentage of patients unsatisfied with their current treatments, we believe Jupiter will be well-positioned to capitalize on the opportunity with our CBD-based proprietary formulation.”

To view the full press release, visit https://cnw.fm/vaHEW

About Jupiter Wellness Inc.

Jupiter Wellness is a leading developer of cannabidiol (“CBD”)-based medical therapeutics and wellness products. The company’s clinical pipeline of prescription CBD-enhanced, skin-care therapeutics address indications including eczema, burns, herpes cold sores and skin cancer. Jupiter generates revenues from a growing line of proprietary over-the-counter skin-care products including its flagship CaniSun(TM) sunscreen and other wellness brands sold through its robust distribution platform. For additional information about this company, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://cnw.fm/JUPW

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

HempNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Engages Top Law Firm to Assist in Omnichannel Retail Strategy

Green Hygienics Holdings (OTCQB: GRYN) (“GHH”) has announced its engagement of the services of McAllister Garfield, P.C., a top law firm in the industrial hemp space. According to the update, Green Hygienics anticipates rapid growth in 2021 and intends to roll out an omnichannel bricks and clicks retail strategy premiering multiple premium brands layering over different market segments in the hemp industry. The company has retained McAllister Garfield, a pioneering law firm in the hemp space, to advise and assist in navigating regulatory compliance and in the roll out of cannabinoid-based product lines and retail opportunities. The firm will assist GHH to secure three business licenses in the downtown vicinity of San Diego for a hemp-centric coffee house, a smoking lounge and a dispensary. “When lawmakers tighten the belt on hemp regulations, Green Hygienics is positioning itself to sustain and thrive under the most stringent of new regulations,” said GRYN CEO Ronald Loudoun. “Navigating regulatory compliance in an emerging industry is no small task, but a very important one to our company, and retaining counsel of such an established law firm with an innate understanding of cannabis law is a necessary step as we build out our highly differentiated business model.”

To view the full press release, visit https://cnw.fm/pyTlW

About Green Hygienics Holdings Inc.

Green Hygienic Holdings (“GHH”) is a California-based, innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. GHH’s mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partnering with CPG (consumer-packaged-goods) and pharmaceutical companies. Green Hygienic Holdings intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, GHH intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration, and bioavailability. The company is building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve lives. For more information, please visit the Corporate Video Link and www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – HempFusion Wellness Inc. Announces TSX Conditional Approval, Filing of Final Prospectus and IPO Pricing

HempFusion Wellness, a leader in the health and wellness cannabidiol (“CBD”) industry, on Friday announced that it has obtained a receipt for its final prospectus filed with the securities regulatory authorities in each of the provinces of Canada, except Québec. According to the update, the final prospectus was filed in connection with HempFusion’s previously-announced initial public offering of up to 7,000,000 common shares and up to 10,000,000 units of the company at a price of US$1.00 per offered share and per unit for gross proceeds of up to US$17,000,000. The offering is being made through a syndicate of agents led by sole bookrunner, Canaccord Genuity Corp., and including Haywood Securities Inc. and PI Financial Corp. (collectively, the “agents”). Under the terms of an agency agreement, HempFusion has granted the agents an over-allotment option, exercisable in whole or in part, at the sole discretion of the agents, at any time and from time to time, for a period of 30 days following the closing of the offering, to purchase up to an additional 15% of the offered shares and the units issued pursuant to the offering at the offering price for additional gross proceeds of up to USD$2,550,000 to the company. Subject to customary requirements, the TSX has conditionally approved the listing of the common shares (including the offered shares, the unit shares and the warrant shares), the warrants and the issued and outstanding common share purchase warrants of the company (the “2019 warrants”) issued in connection with the company’s offering of units completed in August 2019, each 2019 warrant exercisable to acquire one common share of the company (a “2019 warrant share”) until Feb. 28, 2023, at an exercise price of US$0.85 per common share. Subject to customary conditions, the offering is expected to close on or about Jan. 6, 2021, at which point the following securities of the company will commence trading on the TSX: the common shares under the symbol “CBD.U,” the warrants under the symbol “CBD.WT.V” and the 2019 warrants under the symbol “CBD.WT.U.”

To view the full press release, visit https://cnw.fm/mWvZF

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 U.S. states and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs including tinctures, proprietary FDA Drug-listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on R&D, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Corporate Updates, New Strategic Focus

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Friday provided an update on its 49%-owned joint venture, PharmHouse Inc. Per the update, on Oct. 29, 2020, PharmHouse received a court order from the Ontario Superior Court of Justice to initiate a sale and investment solicitation process (“SISP”) to identify interest in, and opportunities for, a sale of, or investment in, all or part of PharmHouse’s assets or business. This may include a restructuring, recapitalization, or other form of reorganization of PharmHouse’s business and affairs. Phase one of the SISP concluded on Nov. 30, 2020, and a number of non-binding offers were received. PharmHouse, with the assistance of the monitor and the SISP advisor, has selected a number of parties to bring forward to the next phase of the SISP, and binding offers for phase two are due on or about Feb. 16, 2021.

In addition, Canopy Rivers today announced its entry into a definitive agreement with Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) pursuant to which, among other things, Canopy Rivers will transfer three portfolio assets to Canopy Growth in exchange for $115 million in cash and 3,750,000 common shares of Canopy Growth and the cancellation of all 36,468,318 Multiple Voting Shares (“MVS”) and the 15,223,938 Subordinate Voting Shares (“SVS”) of Canopy Rivers held by Canopy Growth (collectively, the “transaction”). On closing, the transaction will result in Canopy Rivers becoming a widely-held company and will unlock substantial value, providing it with significant additional cash resources and allowing it to pursue opportunities in the global cannabis market, including the United States. “This is a transformative transaction for our company that we believe provides substantial value to our shareholders through an enhanced cash position and strategic flexibility, and the collapse of our dual class share structure,” said Narbe Alexandrian, president and CEO of Canopy Rivers. “Following the closing of the transaction, we intend to shift our focus to pursuing other opportunities in the global cannabis market, where we believe that our new strategic focus and substantial balance sheet will allow us to successfully execute our revamped strategic plan.”

To view the full press releases, visit https://cnw.fm/fcsm3 and https://ccw.fm/vGdez

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging industry insights, in-house expertise and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders exposure to specialized and disruptive cannabis companies. Canopy Rivers’ mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, the company is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) to Showcase Exclusive CBD-Infused CaniSun Suncare Line at Surf Expo 2021

Jupiter Wellness (NASDAQ: JUPW), a leading developer of innovative skin-care products, lotions, medical therapeutics and wellness products, will kick off the new year by participating in Surf Expo 2021, the largest watersport, beach and resort lifestyle tradeshow in the world. Scheduled for Jan. 6–8, 2021, Surf Expo 2021 will be held at the Orange County Convention Center in Orlando, Florida. More than 28,000 buyers attend the gathering every year; the buyers represent specialty stores, major chains, resorts, cruise lines, marinas and beach-rental companies from the United States, the Caribbean, and Central and South America. Jupiter Wellness will be displaying its Canisun(TM) suncare product line; the line features patent-pending products infused with CBD. Recent reports indicate that CBD has been clinically shown to protect the viability of skin cells from ultraviolet B (“UVB”) irradiation. Surf Expo offers Jupiter Wellness an opportunity for targeted expansion of distribution channels. “Canisun CBD-infused Suncare Products will be on display at Surf Expo along with our recently published skin cell study and the clinical study we just announced November 24 for the treatment of actinic keratosis (AK), the most common precancer that forms on the skin as a result of exposure to UV rays,” said Jupiter Wellness CEO Brian John in the press release. “Surf Expo provides a great opportunity to meet buyers and expand distribution.”

To view the full press release, visit https://cnw.fm/52mFt

About Jupiter Wellness Inc.

Jupiter Wellness is a leading developer of cannabidiol (“CBD”)-based medical therapeutics and wellness products. The company’s clinical pipeline of prescription CBD-enhanced, skin-care therapeutics address indications including eczema, burns, herpes cold sores and skin cancer. Jupiter Wellness generates revenues from a growing line of proprietary over-the-counter, skin-care products including its flagship CaniSun sunscreen and other wellness brands sold through its distribution platform. For more information, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://cnw.fm/JUPW

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Commences Trading on the OTCQB Venture Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced that it has commenced trading in the United States on the OTCQB Venture Market under the symbol “PACRF.” The company anticipates that its new U.S. listing will provide greater liquidity and a more seamless trading experience for its U.S. shareholders and potential investors. “With the cannabis industry gaining momentum in the United States, this cross-border listing will increase our visibility and open the doors to new investors as well as enable exciting business opportunities,” said Pac Roots president and CEO Patrick Elliott.

To view the full press release, visit https://cnw.fm/6fF1x

About Pac Roots Cannabis Corp.

Pac Roots is the future of genetics. By focusing on elite cannabis genetic development, the company maximizes the quality of its products, by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners; Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars as well as its JV partnership with Rock Creek Farms and Speakeasy Cannabis Club, leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within their first year of trading. For more information about the company, visit www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots are available in the company’s newsroom at http://cnw.fm/PACR 

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Happy Supplements Inc. (CSE: FITT) Commences Trading on the CSE

Happy Supplements (CSE: FITT) has announced that its common shares began trading on the Canadian Securities Exchange at 9:30 a.m. Eastern Time on Monday, Dec. 14, 2020, under the ticker symbol FITT. “In 2019 our team set out to create a leading beverage company in the wellness sector,” said Michael Gonzalez, founder of Happy Supplements. “In a short time, we have achieved significant success and are very excited by the public listing of Happy Supplements. We are encouraged by the continued, robust growth of the health beverage market. Our team has a strong track record in this sector, and we will be using our deep knowledge of international marketing and distribution to create a compelling global brand.”

To view the full press release, visit https://cnw.fm/p1HgB

About Happy Supplements Inc.

Happy Supplements is an innovative beverage cannabis company focused on delivering high quality CBD beverages both online and through local market retailers. Happy Supplements utilizes social media to deliver educational experiences with its customer base while demonstrating the company’s innovative beverage technology. For more information, visit www.HappyTea.com.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.